Clinical Neurology and Neurosurgery
Volume 112, Issue 3 , Pages 193-198 , April 2010

Could Helicobacter pylori play an important role in axonal type of Guillain-Barré Syndrome pathogenesis?

  • Mojdeh Ghabaee

      Affiliations

    • Iranian Center of Neurological Research, Neurology Department, Tehran University of Medical Sciences, Iran
  • ,
  • Davod Ghanbarian

      Affiliations

    • Iranian Center of Neurological Research, Neurology Department, Tehran University of Medical Sciences, Iran
    • Corresponding Author InformationCorresponding author. Tel.: +98 21 6690 4777; fax: +98 21 6649 5655.
  • ,
  • Gholamreza Nikbakht Brujeni

      Affiliations

    • Department of Microbiology and Immunology, Faculty of Veterinary Medicine, University of Tehran, Iran
  • ,
  • Saeed Bokaei

      Affiliations

    • Division of Epidemiology, Department of Food Hygiene, Faculty of Veterinary Medicine, University of Tehran, Tehran, Iran
  • ,
  • Farideh Siavoshi

      Affiliations

    • Department of Microbiology, Faculty of Sciences, University of Tehran, Iran
  • ,
  • Shahriar Gharibzadeh

      Affiliations

    • Neuromuscular Systems Laboratory, Faculty of Biomedical Engineering, Amirkabir University of Technology, Iran

Received 15 March 2009 ,Revised 7 November 2009 ,Accepted 13 November 2009.

References 

  1. Bradley W, Daroff R, Marseden C. Neurology in clinical practice. 5th ed.. Heineman: Butterworth; 2008;p. 2249–355
  2. Moran AP, Prendergast MM. Molecular mimicry in Campylobacter jejuni and Helicobacter pylori lipopolysaccharides: contribution of gastrointestinal infections to autoimmunity. J Autoimmun. 2001;16(May(3)):241–256
  3. Kostrzynska M, Betts JD, Austin JW, Trust TJ. Identification, characterization, and spatial localization of two flagellin species in Helicobacter pylori flagella. J Bacteriol. 1991;173(February(3)):937–946
  4. Marshall BJ. Epidemiology of H. pylori in western countries. In:  Hunt RH,  Tytgat GNJ editor. Helicobacter pylori: basic mechanism to clinical cure. Lancaster: Kluwer; 1994;p. 75–84
  5. Whincup PH, Mendall MA, Perry IJ, Strachan DP, Walker M. Prospective relations between Helicobacter pylori infection, coronary heart disease, and stroke in middle aged men. Heart. 1996;75(June(6)):568–572
  6. Gasbarrini A, Franceschi F, Tartaglione R, Landolfi R, Pola P, Gasbarrini G. Regression of autoimmune thrombocytopenia after eradication of Helicobacter pylori. Lancet. 1998;352(September(9131)):878;[no abstract available]
  7. Kountouras J, Gavalas E, Zavos C, Stergiopoulos C, Chatzopoulos D, Kapetanakis N, et al. Alzheimer's disease and Helicobacter pylori infection: defective immune regulation and apoptosis as proposed common links. Med Hypotheses. 2007;68(2):378–388[Epub September 18, 2006]
  8. Chiba S, Sugiyama T, Matsumoto H, Hisano K, Awakawa T, Hiura K, et al. Antibodies against Helicobacter pylori were detected in the cerebrospinal fluid obtained from patients with Guillain-Barré Syndrome. Ann Neurol. 1998;44(October(4)):686–688
  9. Chiba S, Sugiyama T, Yonekura K, Tanaka S, Matsumoto H, Fujii N, et al. An antibody to VacA of Helicobacter pylori in cerebrospinal fluid from patients with Guillain-Barré Syndrome. J Neurol Neurosurg Psychiatry. 2002;73(July(1)):76–78
  10. Chiba S, Sugiyama T, Yonekura K, Tanaka S, Matsumoto H, Fujii N, et al. An antibody to VacA of Helicobacter pylori in the CSF of patients with Miller-Fisher Syndrome. Neurology. 2004;63(December(11)):2184–2186
  11. Kountouras J, Deretzi G, Zavos C, Karatzoglou P, Touloumis L, Nicolaides T, et al. Association between Helicobacter pylori infection and acute inflammatory demyelinating polyradiculoneuropathy. Eur J Neurol. 2005;12(February(2)):139–143
  12. Asbury AK, Cornblath DR. Assessment of current diagnostic criteria for Guillain-Barré Syndrome. Ann Neurol. 1990;(27 Suppl):S21–S24
  13. Ho TW, Mishu B, Li CY, Gao CY, Cornblath DR, Griffin JW, et al. Guillain-Barré Syndrome in northern China relationship to Campylobacter jejuni infection and anti-glycolipid antibodies. Brain. 1995;118:597–605
  14. Griffin JW, Li CY, Ho TW, Tian M, Gao CY, Xue P, et al. Pathology of the motor-sensory axonal Guillain-Barré Syndrome. Ann Neurol. 1996;39(January(1)):17–28
  15. Hughes RA, Newsom-Davis JM, Perkin GD, Pierce JM. Steroids in acute polyneuropathy. Lancet. 1978;2(December(8104–5)):1383
  16. Wisdom GB. Enzyme-immunoassay. Clin Chem. 1976;22(August(8)):1243–1255
  17. Bakos N, Fekete B, Prohászka Z, Füst G, Kalabay L. High prevalence of IgG and IgA antibodies to 19-kDa Helicobacter pylori-associated lipoprotein in chronic urticaria. Allergy. 2003;58(July(7)):663–667
  18. Epidemiology of, and risk factors for, Helicobacter pylori infection among 3194, symptomatic subjects in 17 populations. The EUROGAST Study Group. Gut 1993;34(December(12)):1672–6.
  19. Bosch EP. Guillain-Barré Syndrome: an update of acute immune-mediated polyradiculoneuropathies. Neurologist. 1998;4:211–226
  20. Rudi J, Kolb C, Maiwald M, Zuna I, von Herbay A, Galle PR, et al. Serum antibodies against Helicobacter pylori proteins VacA and CagA are associated with increased risk for gastric adenocarcinoma. Dig Dis Sci. 1997;42(August(8)):1652–1659
  21. Takahashi T, Yujiri T, Shinohara K, Inoue Y, Sato Y, Fujii Y, et al. Molecular mimicry by Helicobacter pylori CagA protein may be involved in the pathogenesis of H. pylori-associated chronic idiopathic thrombocytopenic purpura. Br J Haematol. 2004;124(January(1)):91–96
  22. Vilaichone RK, Mahachai V, Kositchaiwat C, Graham DY, Yamaoka Y. Relation between seroreactivity to low-molecular-weight Helicobacter pylori-specific antigens and disease presentation. Clin Diagn Lab Immunol. 2003;10(November(6)):1025–1028
  23. Morimoto N, Takeuchi H, Takahashi T, Ueta T, Tanizawa Y, Kumon Y, et al. Helicobacter pylori-associated chronic idiopathic thrombocytopenic purpura and low molecular weight H. pylori proteins. Scand J Infect Dis. 2007;39(5):409–416

PII: S0303-8467(09)00305-9

doi: 10.1016/j.clineuro.2009.11.008

Clinical Neurology and Neurosurgery
Volume 112, Issue 3 , Pages 193-198 , April 2010